"Structured override reasons for drug-drug interaction alerts in electronic ..."

Adam Wright et al. (2019)

> Home

Details and statistics

DOI: 10.1093/JAMIA/OCZ033

access: closed

type: Journal Article

metadata version: 2023-11-22

- view
  - electronic edition via DOI
  - unpaywalled version
  authority control:
- export record
  dblp key:
  - journals/jamia/WrightMAMAKACDE19
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/jamia/WrightMAMAKACDE19
Adam Wright, Dustin S. McEvoy, Skye Aaron, Allison B. McCoy, Mary G. Amato, Hyun Kim, Angela Ai, James J. Cimino, Bimal R. Desai, Robert E. El-Kareh, William L. Galanter, Christopher A. Longhurst, Sameer Malhotra, Ryan Radecki, Lipika Samal, Richard Schreiber, Eric D. Shelov, Anwar Mohammad Sirajuddin, Dean F. Sittig:
Structured override reasons for drug-drug interaction alerts in electronic health records. J. Am. Medical Informatics Assoc. 26(10): 934-942 (2019)

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.